Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ESF1 nucleolar pre-rRNA processing protein homolog (ESF1) is an RNA-binding protein encoded by the *ESF1* gene (HGNC:15898), located on chromosome 20. ESF1 plays a role in rRNA processing and is implicated in the regulation of basal transcription, possibly constituting a novel regulatory system. It localizes predominantly to the nucleolus and is associated with RNA metabolic pathways. ESF1 is upregulated in estrogen receptor-positive breast cancer, where its expression correlates with tumor proliferation and poor patient prognosis. Knockdown of ESF1 inhibits colony formation, increases apoptosis, and impairs wound healing in breast cancer cell models. Diseases linked to ESF1 include familial hypocalciuric hypercalcemia type I. At present, ESF1 is not associated with any known drug interactions or targeted therapies, but its association with cancer proliferation suggests potential as a future therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ESF1 nucleolar pre-rRNA processing protein homolog (ESF1).